VYNDAMAX
VYNDAMAX
Approved
DIN Number
02517841
Drug Class
Human
Market Date
Sep 15, 2021
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02517841
AIG Number0163049001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX08 TAFAMIDIS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
Health Canada Classification
ACTIVE INGREDIENTS (1)
TAFAMIDISActive
Strength: 61 MG
Monograph: TAFAMIDIS